Vendor, Winnipeg, CAN, part of Emergent Biosolutions Inc.
Emergent Biosolutions Canada Inc.
UEI XM23STFMVML6, CAGE L0EM2
2 awards and $355,528,256 obligated between February 22, 2024 and May 27, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $355,528,256 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $355,528,256 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50119C00075Definitive Contract, February 23, 2024, Not Competed, 1 offers | Aspr/Orm-SnsOffice of Assistant Secretary for Preparedness and Response | EO14042 Botulism AntitoxinNAICS 325412, PSC 6505 | $187,180,193 |
| 75A50119C00037Definitive Contract, February 22, 2024, Not Competed, 1 offers | Aspr/Orm-SnsOffice of Assistant Secretary for Preparedness and Response | Vaccinia Immune Globulin Intravenous (Vig-Iv) Buy and Associated Services for Up to 10 Years.NAICS 325412, PSC 6505 | $168,348,063 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 15 across 2 awards